Dolby Laboratories’ (DLB) Buy Rating Reiterated at Rosenblatt Securities

Rosenblatt Securities restated their buy rating on shares of Dolby Laboratories (NYSE:DLB) in a research note released on Friday morning,Benzinga reports. Rosenblatt Securities currently has a $85.00 price objective on the electronics maker’s stock.

Several other research firms also recently issued reports on DLB. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Monday, January 5th. Barrington Research reduced their price objective on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a report on Monday, January 26th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Dolby Laboratories currently has an average rating of “Moderate Buy” and an average price target of $90.75.

Dolby Laboratories Price Performance

DLB stock opened at $64.19 on Friday. The company’s 50-day moving average is $65.07 and its 200-day moving average is $68.80. The stock has a market capitalization of $6.13 billion, a PE ratio of 25.88 and a beta of 0.86. Dolby Laboratories has a 1 year low of $60.14 and a 1 year high of $85.49.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings results on Thursday, January 29th. The electronics maker reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.99 by $0.07. Dolby Laboratories had a return on equity of 11.50% and a net margin of 17.97%.The business had revenue of $346.71 million for the quarter, compared to the consensus estimate of $341.26 million. During the same period in the prior year, the business earned $1.14 EPS. The firm’s revenue for the quarter was down 2.8% on a year-over-year basis. On average, analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 18th. Investors of record on Tuesday, February 10th will be issued a dividend of $0.36 per share. The ex-dividend date is Tuesday, February 10th. This represents a $1.44 annualized dividend and a yield of 2.2%. Dolby Laboratories’s payout ratio is 58.06%.

Insider Activity

In other news, CEO Kevin J. Yeaman sold 6,751 shares of the company’s stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $67.24, for a total value of $453,937.24. Following the completion of the transaction, the chief executive officer directly owned 98,377 shares of the company’s stock, valued at $6,614,869.48. This represents a 6.42% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction on Friday, November 21st. The stock was sold at an average price of $65.55, for a total value of $196,650.00. Following the sale, the senior vice president owned 67,435 shares in the company, valued at $4,420,364.25. This trade represents a 4.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 137,120 shares of company stock valued at $9,184,809. 37.93% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Dolby Laboratories

Several large investors have recently made changes to their positions in the business. First Horizon Corp purchased a new position in shares of Dolby Laboratories in the 3rd quarter worth about $25,000. Hantz Financial Services Inc. raised its holdings in shares of Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after purchasing an additional 220 shares during the period. Allworth Financial LP lifted its stake in Dolby Laboratories by 590.4% in the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Mather Group LLC. bought a new position in Dolby Laboratories during the third quarter valued at $38,000. Finally, Rothschild Investment LLC grew its holdings in Dolby Laboratories by 4,046.7% during the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after purchasing an additional 607 shares during the period. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories News Summary

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Company raised FY‑2026 and Q2 guidance well above Street estimates (FY EPS 4.30–4.45 vs. consensus ~3.79; Q2 EPS 1.29–1.44). The stronger outlook is the main catalyst supporting the stock today.
• Positive Sentiment: Dolby announced a quarterly dividend of $0.36 per share (yield ~2.3%), which can attract income-oriented investors and support the share price around the ex‑dividend date.
• Positive Sentiment: Rosenblatt reaffirmed a “Buy” rating with an $85 price target, adding analyst support and upside narrative for investors. Benzinga
• Neutral Sentiment: Q1 results beat consensus on EPS ($1.06 vs. ~$0.99) and revenue (~$346.7M vs. ~341M), indicating operational resilience even as some metrics softened. PR Newswire
• Negative Sentiment: Revenue and EPS were down year-over-year (revenue down ~2.8%), driven by weaker licensing, which triggered an after‑hours selloff after the print and remains a near-term risk. Zacks
• Negative Sentiment: Operational and cash-flow pressures were noted (operating profit and net income declined; temporary negative operating cash flow and higher capex flagged by third‑party summaries), which could weigh on near‑term margins and investor sentiment. Quiver Quant

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.